These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33839064)

  • 1. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
    Sgadari C; Monini P; Tripiciano A; Picconi O; Casabianca A; Orlandi C; Moretti S; Francavilla V; Arancio A; Paniccia G; Campagna M; Bellino S; Meschiari M; Nozza S; Sighinolfi L; Latini A; Muscatello A; Saracino A; Di Pietro M; Galli M; Cafaro A; Magnani M; Ensoli F; Ensoli B
    Front Immunol; 2019; 10():233. PubMed ID: 30815001
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.
    Ensoli B; Bellino S; Tripiciano A; Longo O; Francavilla V; Marcotullio S; Cafaro A; Picconi O; Paniccia G; Scoglio A; Arancio A; Ariola C; Ruiz Alvarez MJ; Campagna M; Scaramuzzi D; Iori C; Esposito R; Mussini C; Ghinelli F; Sighinolfi L; Palamara G; Latini A; Angarano G; Ladisa N; Soscia F; Mercurio VS; Lazzarin A; Tambussi G; Visintini R; Mazzotta F; Di Pietro M; Galli M; Rusconi S; Carosi G; Torti C; Di Perri G; Bonora S; Ensoli F; Garaci E
    PLoS One; 2010 Nov; 5(11):e13540. PubMed ID: 21085635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
    Nicoli F; Chachage M; Clowes P; Bauer A; Kowour D; Ensoli B; Cafaro A; Maboko L; Hoelscher M; Gavioli R; Saathoff E; Geldmacher C
    BMC Infect Dis; 2016 Jul; 16():344. PubMed ID: 27450538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
    Ensoli F; Cafaro A; Casabianca A; Tripiciano A; Bellino S; Longo O; Francavilla V; Picconi O; Sgadari C; Moretti S; Cossut MR; Arancio A; Orlandi C; Sernicola L; Maggiorella MT; Paniccia G; Mussini C; Lazzarin A; Sighinolfi L; Palamara G; Gori A; Angarano G; Di Pietro M; Galli M; Mercurio VS; Castelli F; Di Perri G; Monini P; Magnani M; Garaci E; Ensoli B
    Retrovirology; 2015 Apr; 12():33. PubMed ID: 25924841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection.
    Pallikkuth S; Fischl MA; Pahwa S
    J Infect Dis; 2013 Nov; 208(10):1613-23. PubMed ID: 23922374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
    Bellino S; Tripiciano A; Picconi O; Francavilla V; Longo O; Sgadari C; Paniccia G; Arancio A; Angarano G; Ladisa N; Lazzarin A; Tambussi G; Nozza S; Torti C; Focà E; Palamara G; Latini A; Sighinolfi L; Mazzotta F; Di Pietro M; Di Perri G; Bonora S; Mercurio VS; Mussini C; Gori A; Galli M; Monini P; Cafaro A; Ensoli F; Ensoli B
    Retrovirology; 2014 Jun; 11():49. PubMed ID: 24961156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 residual viremia correlates with persistent T-cell activation in poor immunological responders to combination antiretroviral therapy.
    Mavigner M; Delobel P; Cazabat M; Dubois M; L'faqihi-Olive FE; Raymond S; Pasquier C; Marchou B; Massip P; Izopet J
    PLoS One; 2009 Oct; 4(10):e7658. PubMed ID: 19876401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual Viremia Is Linked to a Specific Immune Activation Profile in HIV-1-Infected Adults Under Efficient Antiretroviral Therapy.
    Younas M; Psomas C; Reynes C; Cezar R; Kundura L; Portalès P; Merle C; Atoui N; Fernandez C; Le Moing V; Barbuat C; Sotto A; Sabatier R; Winter A; Fabbro P; Vincent T; Reynes J; Corbeau P
    Front Immunol; 2021; 12():663843. PubMed ID: 33859653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
    Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
    AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
    Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
    Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART.
    Zhang LX; Jiao YM; Zhang C; Song JW; Fan X; Xu RN; Huang HH; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS
    Front Immunol; 2020; 11():1541. PubMed ID: 32793212
    [No Abstract]   [Full Text] [Related]  

  • 14. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of CD8+ T cell immunity and viral escape following acute HIV-1 infection.
    Cao J; McNevin J; Malhotra U; McElrath MJ
    J Immunol; 2003 Oct; 171(7):3837-46. PubMed ID: 14500685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in frequencies of circulating Th-17 cells correlates with microbial translocation, immune activation and exhaustion in HIV-1 infected patients with poor CD4 T-cell reconstitution.
    Valiathan R; Asthana D
    Immunobiology; 2016 May; 221(5):670-8. PubMed ID: 26817581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous CD4 T Lymphocytes Modified with a Tat-Dependent, Virus-Specific Endoribonuclease Gene in HIV-Infected Individuals.
    Jacobson JM; Jadlowsky JK; Lacey SF; Fraietta JA; Plesa G; Chono H; Lee DH; Kulikovskaya I; Bartoszek C; Chen F; Tian L; Dimitri A; Levine BL; Veloso EA; Hwang WT; June CH
    Mol Ther; 2021 Feb; 29(2):626-635. PubMed ID: 33186691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load.
    Oxenius A; Price DA; Dawson SJ; Günthard HF; Fischer M; Perrin L; Ramirez E; Fagard C; Hirschel B; Scullard G; Weber JN; McLean AR; Phillips RE;
    AIDS; 2002 Nov; 16(17):2317-22. PubMed ID: 12441804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Expression of miR-19b Enhances CD8
    Yin LB; Song CB; Zheng JF; Fu YJ; Qian S; Jiang YJ; Xu JJ; Ding HB; Shang H; Zhang ZN
    Front Immunol; 2018; 9():3140. PubMed ID: 30687333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.